Michael Oellerich | Professor, Department of Clinical Pharmacology
University Medical Center Göttingen, George-August-University Göttingen, Germany

Michael Oellerich, MD, HonMD, FAACC, FAMM, FFPath (RCPI), FRCPath, is a chemical pathologist and
currently a Distinguished Research Professor at the Department of Clinical Pharmacology, Medical Faculty
(UMG) of the George-August University, Göttingen, Germany. From 2012 to 2017 he had an appointment
as Lower Saxony Professor of Clinical Chemistry. He was Chairman of the Department of Clinical
Chemistry/Central Laboratory at UMG (1991-2012), and Dean of the Faculty of Medicine. He served as
President of national and international professional organizations (IATDMCT, DGLM, DGKL, WASPaLM). He
was Editor-in-Chief of Therapeutic Drug Monitoring (2003-2018) and currently is Associate Editor of this
journal. His current research interests are in the field of therapeutic drug monitoring (e.g. cfDNA in cancer
and donor-derived cell-free DNA in transplantation). He has authored more than 500 publications and has
received various awards (e.g. Ludolf-Krehl Award, IATDMCT Charles Pippenger Award, WASPaLM Medal
of Honor, WASPaLM Gold-Headed Cane, Sign of Honor, Professor Jordan Todoroff (BSCL). F. McCreary
Prize for Interprofessional Teamwork, Genome Canada Transplant Consortium, University of British
Columbia, UBC Health, Vancouver (Canada) 2022).